Literature DB >> 11244483

Mutation screening of the Wolfram syndrome gene in psychiatric patients.

R Torres1, E Leroy, X Hu, A Katrivanou, P Gourzis, A Papachatzopoulou, A Athanassiadou, S Beratis, D Collier, M H Polymeropoulos.   

Abstract

Wolfram syndrome, a rare autosomal recessive neurodegenerative disorder, was originally described as a combination of familial juvenile-onset diabetes mellitus and optic atrophy. It was later demonstrated that Wolfram syndrome patients were highly prone to psychiatric disorders. Mutations in exon 8 of the Wolfram syndrome gene account for 88% of the patients with Wolfram syndrome. To examine whether the gene responsible for causing Wolfram syndrome is involved in psychiatric disorders, we screened exon 8 of the Wolfram syndrome gene for mutations in 119 patients with schizophrenia, one patient with schizoaffective disorder, 12 patients with bipolar disorder and 15 patients with major depression, using sequence analysis. In Wolfram syndrome patients, this gene has been shown to have primarily nonsense or frameshift mutations, which would result in a premature truncation of the protein. None of the psychiatric patients screened in this study carried these types of mutations. We identified, however, 24 new variations whose significance remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11244483     DOI: 10.1038/sj.mp.4000787

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  11 in total

1.  Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss.

Authors:  I N Bespalova; G Van Camp; S J Bom; D J Brown; K Cryns; A T DeWan; A E Erson; K Flothmann; H P Kunst; P Kurnool; T A Sivakumaran; C W Cremers; S M Leal; M Burmeister; M M Lesperance
Journal:  Hum Mol Genet       Date:  2001-10-15       Impact factor: 6.150

2.  Molecular characterization of WFS1 in patients with Wolfram syndrome.

Authors:  Johannes M W van ven Ouweland; Kim Cryns; Ronald J E Pennings; Inge Walraven; George M C Janssen; J Antonie Maassen; Bernard F E Veldhuijzen; Alexander B Arntzenius; Dick Lindhout; Cor W R J Cremers; Guy Van Camp; Lambert D Dikkeschei
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

3.  Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin.

Authors:  Anton Terasmaa; Ursel Soomets; Julia Oflijan; Marite Punapart; Mats Hansen; Vallo Matto; Kersti Ehrlich; Anne Must; Sulev Kõks; Eero Vasar
Journal:  J Physiol Biochem       Date:  2011-04-02       Impact factor: 4.158

4.  Two families with nonsyndromic low-frequency hearing loss harbor novel mutations in Wolfram syndrome gene 1.

Authors:  Nicolas Gürtler; Yuil Kim; Anand Mhatre; Christoph Schlegel; Adolf Mathis; Robert Daniels; Clough Shelton; Anil K Lalwani
Journal:  J Mol Med (Berl)       Date:  2005-05-24       Impact factor: 4.599

5.  Autoimmune disease in a DFNA6/14/38 family carrying a novel missense mutation in WFS1.

Authors:  Michael S Hildebrand; Jessica L Sorensen; Maren Jensen; William J Kimberling; Richard J H Smith
Journal:  Am J Med Genet A       Date:  2008-09-01       Impact factor: 2.802

6.  Atypical case of Wolfram syndrome revealed through targeted exome sequencing in a patient with suspected mitochondrial disease.

Authors:  Daniel S Lieber; Scott B Vafai; Laura C Horton; Nancy G Slate; Shangtao Liu; Mark L Borowsky; Sarah E Calvo; Jeremy D Schmahmann; Vamsi K Mootha
Journal:  BMC Med Genet       Date:  2012-01-06       Impact factor: 2.103

7.  Prohormone convertase 2 activity is increased in the hippocampus of Wfs1 knockout mice.

Authors:  Karin Tein; Sergo Kasvandik; Sulev Kõks; Eero Vasar; Anton Terasmaa
Journal:  Front Mol Neurosci       Date:  2015-08-25       Impact factor: 5.639

8.  Phenotype Prediction of Pathogenic Nonsynonymous Single Nucleotide Polymorphisms in WFS1.

Authors:  Xuli Qian; Luyang Qin; Guangqian Xing; Xin Cao
Journal:  Sci Rep       Date:  2015-10-05       Impact factor: 4.379

9.  Effect of chronic valproic Acid treatment on hepatic gene expression profile in wfs1 knockout mouse.

Authors:  Marite Punapart; Mall Eltermaa; Julia Oflijan; Silva Sütt; Anne Must; Sulev Kõks; Leonard C Schalkwyk; Catherine Fernandes; Eero Vasar; Ursel Soomets; Anton Terasmaa
Journal:  PPAR Res       Date:  2014-04-01       Impact factor: 4.964

Review 10.  Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity.

Authors:  C Gragnoli; G M Reeves; J Reazer; T T Postolache
Journal:  Transl Psychiatry       Date:  2016-04-19       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.